» Articles » PMID: 20723847

Optical Coherence Tomography in Multiple Sclerosis: a Systematic Review and Meta-analysis

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2010 Aug 21
PMID 20723847
Citations 232
Authors
Affiliations
Soon will be listed here.
Abstract

Optical coherence tomography (OCT) is a new method that could aid analysis of neurodegeneration in multiple sclerosis (MS) by capturing thinning of the retinal nerve fibre layer (RNFL). Meta-analyses of data for time domain OCT show RNFL thinning of 20.38 microm (95% CI 17.91-22.86, n=2063, p<0.0001) after optic neuritis in MS, and of 7.08 microm (5.52-8.65, n=3154, p<0.0001) in MS without optic neuritis. The estimated RNFL thinning in patients with MS is greater than the extent expected in normal ageing, probably because of retrograde trans-synaptic degeneration and progressive loss of retinal ganglion cells, in addition to the more pronounced thinning caused by optic neuritis if present. RNFL thickness correlates with visual and neurological functioning as well as with paraclinical data. Developments that could improve understanding of the relation between structure and function in MS pathophysiology include spectral or Fourier domain OCT technology, polarisation-sensitive OCT, fluorescence labelling, structural assessment of action-potential propagation, and segmentation algorithms allowing quantitative assessment of retinal layers.

Citing Articles

The Effects of Disease-Modifying Therapies on Optic Nerve Degeneration in Multiple Sclerosis.

Zhang X, Song S, Chen B, Leocani L, Zhao X, Zhong Y Eur J Neurol. 2025; 32(3):e70081.

PMID: 40047132 PMC: 11883414. DOI: 10.1111/ene.70081.


Early Synapse-Specific Alterations of Photoreceptor Mitochondria in the EAE Mouse Model of Multiple Sclerosis.

Ibrahim D, Schwarz K, Suiwal S, Maragkou S, Schmitz F Cells. 2025; 14(3).

PMID: 39936997 PMC: 11816939. DOI: 10.3390/cells14030206.


Optical Coherence Tomography in Huntington's Disease-A Potential Future Biomarker for Neurodegeneration?.

Cerejo C, De Cleene N, Mandler E, Schwarzova K, Labrecque S, Mahlknecht P Neurol Int. 2025; 17(1.

PMID: 39852777 PMC: 11767877. DOI: 10.3390/neurolint17010013.


From diagnosis to treatment: exploring the mechanisms underlying optic neuritis in multiple sclerosis.

Tong B, Zhang X, Hu H, Yang H, Wang X, Zhong M J Transl Med. 2025; 23(1):87.

PMID: 39838397 PMC: 11748848. DOI: 10.1186/s12967-025-06105-1.


Unraveling the inflammation-degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer.

Zanghi A, Greco A, Giancipoli E, Tumani H, Avolio C, DAmico E J Neurol. 2025; 272(2):109.

PMID: 39812684 PMC: 11735525. DOI: 10.1007/s00415-024-12797-0.